Cart
sales@molnova.com
Irtemazole
CAS No. 129369-64-8
Irtemazole( —— )
Catalog No. M34628 CAS No. 129369-64-8
Irtemazole (R 60844) is a novel uricosuric substance that is valuable in the treatment of hyperuricemia and gout.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 170 | Get Quote |
|
| 5MG | 247 | Get Quote |
|
| 10MG | 371 | Get Quote |
|
| 25MG | 601 | Get Quote |
|
| 50MG | 854 | Get Quote |
|
| 100MG | 1134 | Get Quote |
|
| 500MG | 2277 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameIrtemazole
-
NoteResearch use only, not for human use.
-
Brief DescriptionIrtemazole (R 60844) is a novel uricosuric substance that is valuable in the treatment of hyperuricemia and gout.
-
DescriptionIrtemazole (R 60844) is a novel uricosuric substance that is valuable in the treatment of hyperuricemia and gout.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number129369-64-8
-
Formula Weight288.35
-
Molecular FormulaC18H16N4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(C=1C=C2C(=CC1)N=C(C)N2)(N3C=CN=C3)C4=CC=CC=C4
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Inotuzumab
Inotuzumab (Humanized Anti-CD22 Recombinant Antibody) is a humanized IgG4 antibody targeting CD22.
-
(2E,4E)-2,4-Decadien...
(2E,4E)-Decadienoic acid is an anti-oomycete aliphatic compound that can be found in Coculture of Bacillus subtilis and Trichoderma asperellum.
-
OVA Peptide (257-264...
OVA Peptide (257-264) TFA is a class I (Kb)-restricted peptide epitope of OVA, an octameric peptide from ovalbumin presented by the class I MHC molecule, H-2Kb.
